E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer

European Journal of Cancer

Volumn 45, Issue 10, 2009, Pages 1871-1876

  Hebbar, Mohamed ^a   Adenis, Antoine ^b   Révillion, Françoise ^b   Duhamel, Alain ^a   Romano, Olivier ^a   Truant, Stéphanie ^a   Libersa, Christian ^a   Giraud, Claire ^c   Triboulet, Jean Pierre ^a   Pruvot, François René ^a   Peyrat, Jean Philippe ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Oscar Lambret Centre   (France)

^c Léonard de Vinci Centre   (France)

Author keywords

Colorectal cancer; E selectin; Endothelial cells; Polymorphism; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLUOROPYRIMIDINE; OXALIPLATIN; PADGEM PROTEIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL ADHESION; COLORECTAL CANCER; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; ENDOTHELIUM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MONOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; RECTUM CANCER; TUMOR CELL; UNTRANSLATED REGION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA, NEOPLASM; E-SELECTIN; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; P-SELECTIN; POLYMORPHISM, GENETIC; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 67149146449     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.03.011     Document Type: Article

References (27)

1. Coleman M.P., Quaresma M., Berrino F., et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 9 (2008) 730-756
2. Carsin A.E., Sharp L., Cronin-Fenton D.P., Céilleachair A.O., and Comber H. Inequity in colorectal cancer treatment and outcomes: a population-based study. Br J Cancer 99 (2008) 266-274
3. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
4. Twelves C., Wong A., Nowacki M.P., et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 352 (2005) 2696-2704
5. André T., Boni C., Mounedji-Boudiaf L., et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350 (2004) 2343-2351
6. Gill S., Loprinzi C.L., Sargent D.J., et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?. J Clin Oncol 22 (2004) 1797-1806
7. André T., Sargent D., Tabernero J., et al. Current issues in adjuvant treatment of stage II colon cancer. Ann Surg Oncol 13 (2006) 887-898
8. Hebbar M., Révillion F., Louchez M.M., et al. The relationship between concentrations of circulating soluble E-selectin and clinical, biological, and pathological features in patients with breast cancer. Clin Cancer Res 4 (1998) 373-380
9. Recchi M.A., Hebbar M., Hornez L., Harduin-Lepers A., Peyrat J.P., and Delannoy P. Multiplex reverse transcriptase polymerase chain reaction assessment of sialyltransferases expression in human breast cancer. Cancer Res 58 (1998) 4066-4070
10. Hebbar M., Révillion F., Louchez M.M., Fournier C., Bonneterre J., and Peyrat J.P. Prognostic value of circulating soluble E-selectin in node-negative breast cancer patients. Clin Cancer Res 5 (1999) 1427-1435
11. Orr F.W., Wang H.H., Lafrenie R.M., Scherbarth S., and Nance D.M. Interactions between cancer cells and the endothelium in metastasis. J Pathol 190 (2000) 310-329
12. Yamada N., Chung Y.S., Takatsuka S., et al. Increased sialyl Lewis A expression and fucosyltransferase activity with acquisition of a high metastatic capacity in a colon cancer cell line. Br J Cancer 76 (1997) 582-587
13. Thomas S.N., Zhu F., Schnaar R.L., Alves C.S., and Konstantopoulos K. Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J Biol Chem 283 (2008) 15647-15655
14. Wenzel K., Hanke R., and Speer A. Polymorphism in the human E-selectin gene detected by PCR-SSCP. Hum Genet 94 (1994) 452-453
15. Revelle B.M., Scott D., and Beck P.J. Single amino acid residues in the E- and P-selectin epidermal growth factor domains can determine carbohydrate binding specificity. J Biol Chem 271 (1996) 16160-16170
16. Rao R.M., Clarke J.L., Ortlepp S., Robinson M.K., Landis R.C., and Haskard D.O. The S128R polymorphism of E-selectin mediates neuraminidase-resistant tethering of myeloid cells under shear flow. Eur J Immunol 32 (2002) 251-260
17. Rao R.M., Haskard D.O., and Landis R.C. Enhanced recruitment of Th2 and CLA-negative lymphocytes by the S128R polymorphism of E-selectin. J Immunol 169 (2002) 5860-5865
18. Yoshida M., Takano Y., Sasaoka T., Izumi T., and Kimura A. E-selectin polymorphism associated with myocardial infarction causes enhanced leukocyte-endothelial interactions under flow conditions. Arterioscler Thromb Vasc Biol 23 (2003) 783-788
19. Wenzel K., Felix S., Kleber F.X., et al. E-selectin polymorphism and atherosclerosis: an association study. Hum Mol Genet 3 (1994) 1935-1937
20. Auer J., Weber T., Berent R., Lassnig E., Lamm G., and Eber B. Genetic polymorphisms in cytokine and adhesion molecule genes in coronary artery disease. Am J Pharmacogenomics 3 (2003) 317-328
21. Adenis A., Conroy T., Lasser P., et al. French National Federation of Cancer (FNCLCC). Carcinoma of the colon. Br J Cancer 84 (2001) 65-68
22. Livak K.J. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14 (1999) 143-149
23. Lurje G., Zhang W., Schultheis A.M., et al. Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer. Ann Oncol 10 (2008) 1734-1741
24. Alessandro R., Seidita G., Flugy A.M., et al. Role of S128R polymorphism of E-selectin in colon metastasis formation. Int J Cancer 121 (2007) 528-535
25. Meigs J.B., Hu F.B., Perhanidis J.S., Hunter D., Rifai N., and Manson J.E. E-selectin genotypes and risk of type 2 diabetes in women. Obes Res 13 (2005) 513-518
26. Wenzel K., Ernst M., Rohde K., Baumann G., and Speer A. DNA polymorphisms in adhesion molecule genes: a new risk factor for early atherosclerosis. Hum Genet 97 (1996) 15-20
27. Wenzel K., Stahn R., Speer A., et al. Functional characterization of atherosclerosis-associated Ser128Arg and Leu554Phe E-selectin mutations. Biol Chem 380 (1999) 661-667